Alzheimer Disease

Latest News

Alzheimer risk hormone replacement therapy menopause
Alzheimer Disease Risk Found Related to Timing of Hormone Replacement Therapy in Post-Menopausal Patients

September 16th 2025

Timing hormone replacement therapy post-menopause significantly influences Alzheimer disease risk, with early treatment offering protective benefits against cognitive decline.

FDA
FDA Approves Leqembi for At-Home Maintenance Treatment of Alzheimer Disease

August 29th 2025

Alzheimer
Leqembi for Alzheimer Disease Launches in First European Union Countries

August 25th 2025

brain meds
Lithium, Alzheimer Disease, and a Turning Point in Mental Health Care

August 22nd 2025

Alzheimer
Positive Phase 2b/3 Open-Label Extension Trial Results: Blarcamesine for Treatment of Early Alzheimer Disease

July 31st 2025

<1
...
45678
© 2025 MJH Life Sciences

All rights reserved.